Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease

Istanbul Medipol University Hospital121 enrolled

Overview

This study aims to investigate the effect of laser ablation (LA) in minimally invasive management of pilonidal disease (PD). Data of the patients with PD who were eligible for simple debridement have been prospectively collected since March 2018, when laser ablation treatment came into use in our institution. Laser ablation treatment was offered to all eligible patients. All the patients underwent debridement (removal of hair and/or necrotic tissues through pits using a clamp/curette/brush) of PD; LA was added to the procedure in patients who were willing to have LA. The surgical outcome of two procedures was compared. The primary outcome measure was recurrence at 36 months.

Study Type

OBSERVATIONAL

Enrollment

121

Conditions

Pilonidal Disease

Interventions

Laser ablationDEVICE

A diode-laser that has been reported to be safe and effective in several treatments including pilonidal disease, anal fistula, hemorrhoids, and vascular ablation was used to obtain shrinkage of pilonidal cyst

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Class III, IV, and V pilonidal disease according to Tezel Navicular Area Classification * Patients who underwent debridement for pilonidal disease Exclusion Criteria: * Patients with acute abscess (Tezel Class II) * Antibiotic use within 4 weeks before surgery * Patients lost to follow-up at 3,7 and 30 days; 6, 12 and 36 months

Outcomes

Primary Outcomes

disease recurrence at 36 months

Any ongoing or recurrent sypmtoms were recorded

Time frame: 36 months

Secondary Outcomes

Complications after the procedure

Safety of the procedure

Time frame: 1 month

Incidence of adverse events